Back
HuagongsheHuagongshe Chemistry Print Report · For research reference only
HRID 644240Generated: October 29, 2026

2-amino-N-(5-chloropyridin-2-yl)-5-fluorobenzamide → N-(5-Chloropyridin-2-yl)-5-fluoro-2-[4-isopropyl-2-(piperidin-3-yl-methoxy)benzoylamino]benzamide Dihydrochloride

https://huagongshe.com/reaction/644240

Reaction equation

Participants

RoleNameHCIDCharge
Reactant2-amino-N-(5-chloropyridin-2-yl)-5-fluorobenzamideHCID 21906315—
Reactant4-isopropyl-2-(N-tert-butoxycarbonylpiperidin-3-yl)methoxybenzoic acidHCID 68532264—
Reactant2-[4-isopropyl-2-(piperidin-3-yl-methoxy)benzoylamino]-N-(5-chloropyridin-2-yl)-5-fluorobenzamide hydrochlorideHCID 68571122—
ProductN-(5-Chloropyridin-2-yl)-5-fluoro-2-[4-isopropyl-2-(piperidin-3-yl-methoxy)benzoylamino]benzamide DihydrochlorideHCID 68572225—

Reaction Steps

Using methods substantially equivalent to those described in example 60-I & J, 2-[4-isopropyl-2-(piperidin-3-yl-methoxy)benzoylamino]-N-(5-chloropyridin-2-yl)-5-fluorobenzamide hydrochloride (92 mg, 0.15 mmol, 14%) was prepared from 4-isopropyl-2-(N-tert-butoxycarbonylpiperidin-3-yl)methoxybenzoic acid and N-(5-chloropyridin-2-yl)-2-amino-5-fluorobenzamide after reverse phase HPLC purification.

Provenance & Evidence

DOI10.6084/m9.figshare.5104873.v1
Patent numberUS07700628B2
Source datasetuspto-grants-2010_04
ORD IDord-aec0412a1c234dad84c724310f307f2b
Source noteuspto-grants-2010_04